Testing effectiveness (Phase 2)Ended earlyNCT00230334What this trial is testingPhase II Gleevec Idiopathic Hypereosinophilic SyndromeWho this might be right forEosinophiliaHypereosinophilic Syndrome Steven E. Coutre 5
Not applicableStudy completedNCT00038675What this trial is testingTherapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib MesylateWho this might be right forChronic Myelomonocytic LeukemiaChronic Myeloid LeukemiaPolycythemia Vera+2 more M.D. Anderson Cancer Center 125
Not applicableNo Longer AvailableNCT00244686What this trial is testingThis Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With HypereosinophilicWho this might be right forHypereosinophilic Syndrome GlaxoSmithKline
Large-scale testing (Phase 3)Active Not RecruitingNCT04191304What this trial is testingA Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)Who this might be right forHypereosinophilic Syndrome AstraZeneca 134
Testing effectiveness (Phase 2)Active Not RecruitingNCT00044304What this trial is testingTyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic SyndromeWho this might be right forEosinophilic Myeloid NeoplasmHypereosinophilic Syndrome National Institute of Allergy and Infectious Diseases (NIAID) 70
Not applicableLooking for participantsNCT04538937What this trial is testingProspective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing EosinophilsWho this might be right forEosinophilic AsthmaEGPA - Eosinophilic Granulomatosis With PolyangiitisSamter Triad+2 more Medical University Innsbruck 300
Large-scale testing (Phase 3)Looking for participantsNCT05334368What this trial is testingDepemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety TrialWho this might be right forHypereosinophilic Syndrome GlaxoSmithKline 109